{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:13:10Z","timestamp":1792681990949,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Adv Skin Wound Care"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Acne vulgaris is a common chronic skin condition characterized by variable combinations of papules, pustules, cysts, and nodules that invariably arise from comedones. This article focuses on the clinical presentation of acne vulgaris subtypes and treatment options. Other related topics discussed include epidemiology and differential diagnoses.<\/jats:p>\n          <jats:sec>\n            <jats:title>GENERAL PURPOSE<\/jats:title>\n            <jats:p>To review the clinical presentation and treatment of acne vulgaris.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>TARGET AUDIENCE<\/jats:title>\n            <jats:p>This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and registered nurses with an interest in skin and wound care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LEARNING OBJECTIVES\/OUTCOMES<\/jats:title>\n            <jats:p>After participating in this educational activity, the participant will:<\/jats:p>\n            <jats:p>1. Identify a differential diagnosis of acne vulgaris.<\/jats:p>\n            <jats:p>2. Recognize clinical feature of various acne vulgaris subtypes.<\/jats:p>\n            <jats:p>3. Specify epidemiologic characteristics of acne vulgaris.<\/jats:p>\n            <jats:p>4. Select topical, systemic, and nonpharmaceutical treatment options for a patient with acne vulgaris.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/asw.0000000000000089","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T20:00:09Z","timestamp":1705694409000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Acne Vulgaris: Clinical Aspects and Treatments"],"prefix":"10.1097","volume":"37","author":[{"given":"Ryan","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Gary","family":"Sibbald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"bib1-20250615","first-page":"3","article-title":"A global perspective on the epidemiology of acne","volume":"172","year":"2015","journal-title":"Br J Dermatol"},{"issue":"9813","key":"bib3-20250615","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"bib4-20250615","first-page":"3","article-title":"Psychosocial effects of acne","volume":"8","year":"2004","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"bib5-20250615","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"bib6-20250615","first-page":"734","article-title":"Diagnosis and treatment of acne","volume":"86","year":"2012","journal-title":"Am Fam Physician"},{"issue":"5","key":"bib8-20250615","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.clindermatol.2004.03.008","article-title":"The assessment of acne: an evaluation of grading and lesion counting in the measurement of acne","volume":"22","year":"2004","journal-title":"Clin Dermatol"},{"issue":"2","key":"bib9-20250615","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1396-0296.2004.04019.x","article-title":"Acne in ethnic skin: special considerations for therapy","volume":"17","year":"2004","journal-title":"Dermatol Ther"},{"key":"bib13-20250615","first-page":"69","article-title":"Therapeutic options for the follicular occlusion tetrad","volume":"2","year":"1995","journal-title":"Curr Opin Dermatol"},{"issue":"2","key":"bib14-20250615","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40257-022-00746-4","article-title":"truncal acne and scarring: a comprehensive review of current medical and cosmetic approaches to treatment and patient management","volume":"24","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"bib15-20250615","first-page":"13","article-title":"The epidemiology of acne vulgaris in late adolescence","volume":"7","year":"2016","journal-title":"Adolesc Health Med Ther"},{"issue":"2","key":"bib16-20250615","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1503\/cmaj.140665","article-title":"Management of acne: Canadian clinical practice guideline","volume":"188","year":"2016","journal-title":"CMAJ"},{"issue":"6","key":"bib17-20250615","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","article-title":"Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials","volume":"156","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"4","key":"bib18-20250615","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/000155502320323216","article-title":"Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle","volume":"82","year":"2002","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"bib19-20250615","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaad.2019.05.078","article-title":"Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: a phase 3 study","volume":"82","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"bib20-20250615","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0190-9622(97)70177-4","article-title":"Treatment of acne with a combination clindamycin\/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations","volume":"37","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"bib21-20250615","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0378-6323.31892","article-title":"Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris","volume":"73","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"10","key":"bib22-20250615","first-page":"5","article-title":"Benzoyl peroxide: enhancing antibiotic efficacy in acne management","volume":"15","year":"2010","journal-title":"Skin Ther Lett"},{"issue":"7","key":"bib23-20250615","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/1346-8138.13798","article-title":"Twelve-week, multicenter, placebo-controlled, randomized, double-blind, parallel-group, comparative phase II\/III study of benzoyl peroxide gel in patients with acne vulgaris: a secondary publication","volume":"44","year":"2017","journal-title":"J Dermatol"},{"issue":"10","key":"bib24-20250615","first-page":"18","article-title":"Efficacy, safety, and dermal tolerability of dapsone gel, 7.5% in patients with moderate acne vulgaris: a pooled analysis of two phase 3 trials","volume":"9","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"bib25-20250615","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jocd.12031","article-title":"Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV)","volume":"12","year":"2013","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"bib26-20250615","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/09546639609089537","article-title":"The benefit of 2% salicylic acid lotion in acne a placebo-controlled study","volume":"7","year":"1996","journal-title":"J Dermatol Treat"},{"issue":"4","key":"bib27-20250615","first-page":"459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","year":"2003","journal-title":"Arch Dermatol"},{"issue":"9","key":"bib28-20250615","first-page":"987","article-title":"Once-daily oral sarecycline 1.5 mg\/kg\/day is effective for moderate to severe acne vulgaris: results from two identically designed, phase 3, randomized, double-blind clinical trials","volume":"17","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"bib29-20250615","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-4632.2008.03445.x","article-title":"Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial","volume":"47","year":"2008","journal-title":"Int J Dermatol"},{"issue":"1","key":"bib30-20250615","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.contraception.2009.02.016","article-title":"Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled phase III trial","volume":"80","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"bib31-20250615","first-page":"83","article-title":"Combined oral contraceptives for the treatment of acne: a practical guide","volume":"90","year":"2012","journal-title":"Cutis"},{"issue":"3","key":"bib32-20250615","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/mjd.2000.105557","article-title":"Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients","volume":"43","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"bib33-20250615","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijwd.2016.12.002","article-title":"Spironolactone for the treatment of acne in women, a retrospective study of 110 patients","volume":"3","year":"2017","journal-title":"Int J Womens Dermatol"},{"issue":"4 Pt 2 Suppl","key":"bib34-20250615","first-page":"735","article-title":"Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study","volume":"6","year":"1982","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"bib35-20250615","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/0019-5154.131455","article-title":"Safety and efficacy of low-dose isotretinoin in the treatment of moderate to severe acne vulgaris","volume":"59","year":"2014","journal-title":"Indian J Dermatol"}],"container-title":["Advances in Skin &amp; Wound Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ASW.0000000000000089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T21:00:28Z","timestamp":1750021228000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ASW.0000000000000089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/asw.0000000000000089","relation":{},"ISSN":["1538-8654","1527-7941"],"issn-type":[{"value":"1538-8654","type":"electronic"},{"value":"1527-7941","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}